Cargando…

Neurofascin and Compact Myelin Antigen-Specific T Cell Response Pattern in Chronic Inflammatory Demyelinating Polyneuropathy Subtypes

OBJECTIVE: The objective of this study is to investigate whether chronic inflammatory demyelinating polyneuropathy (CIDP) and its subtypes differ in their type 1 T-helper (TH1) cell response against nodal/paranodal neurofascin (NF186, NF155) as well as myelin protein zero (P0 180–199) and myelin bas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diederich, Jan-Markus, Staudt, Maximilian, Meisel, Christian, Hahn, Katrin, Meinl, Edgar, Meisel, Andreas, Klehmet, Juliane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868132/ https://www.ncbi.nlm.nih.gov/pubmed/29615965 http://dx.doi.org/10.3389/fneur.2018.00171

Ejemplares similares

Neurofascin (NF)155- and NF186-Specific T Cell Response in a Patient Developing a Central Pontocerebellar Demyelination after 10 Years of CIDP
por: Klehmet, Juliane, et al.
Publicado: (2017)

Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP
por: Staudt, M., et al.
Publicado: (2017)

Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants—A Potential Novel Biomarker of Disease Activity
por: Stascheit, Frauke, et al.
Publicado: (2021)

Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy
por: Klehmet, Juliane, et al.
Publicado: (2019)

Tremor Associated with Chronic Inflammatory Demyelinating Polyneuropathy and Anti‐Neurofascin‐155 Antibodies
por: Bailly, Laurent, et al.
Publicado: (2018)

Anti-Neurofascin–Associated Nephrotic-Range Proteinuria in Chronic Inflammatory Demyelinating Polyneuropathy
por: Bukhari, Syed, et al.
Publicado: (2020)

Autoantibodies to a Nodal Isoform of Neurofascin in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
por: Chauvet, Eline, et al.
Publicado: (2023)

Impact of Neurofascin on Chronic Inflammatory Demyelinating Polyneuropathy via Changing the Node of Ranvier Function: A Review
por: Gao, Ying, et al.
Publicado: (2021)

Neurofascin-155 as a putative antigen in combined central and peripheral demyelination
por: Cortese, Andrea, et al.
Publicado: (2016)

Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy
por: Klehmet, Juliane, et al.
Publicado: (2023)

Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta‐analysis
por: Hu, Wenyu, et al.
Publicado: (2018)

Presence of both anti-contactin 1 and anti-neurofascin 140 antibodies in a case of chronic inflammatory demyelinating polyneuropathy
por: Lin, Hsin-Pin, et al.
Publicado: (2018)

Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism
por: Kira, Jun-ichi
Publicado: (2021)

Autoantibodies Against the Node of Ranvier in Seropositive Chronic Inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic Relevance
por: Vural, Atay, et al.
Publicado: (2018)

Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination
por: Efthymiou, Stephanie, et al.
Publicado: (2019)

Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy
por: Ogata, Hidenori, et al.
Publicado: (2015)

Macrophages are scavengers for injured myelin in a rabbit model of acute inflammatory demyelinating polyneuropathy
por: Xu, Jie, et al.
Publicado: (2023)

Oligodendrocyte Neurofascin Independently Regulates Both Myelin Targeting and Sheath Growth in the CNS
por: Klingseisen, Anna, et al.
Publicado: (2019)

Neurofascin as a novel target for autoantibody-mediated axonal injury
por: Mathey, Emily K., et al.
Publicado: (2007)

Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes
por: Shelly, Shahar, et al.
Publicado: (2021)

Optic Nerve Demyelination in IgG4 Anti–Neurofascin 155 Antibody–Positive Combined Central and Peripheral Demyelination Syndrome
por: Verghese, Alice, et al.
Publicado: (2021)

Combined Central and Peripheral Demyelination With IgM Anti–Neurofascin 155 Antibodies: Case Report
por: Pegat, Antoine, et al.
Publicado: (2022)

Myelination, Dysmyelination, and Demyelination
por: Jean Harry, G., et al.
Publicado: (1998)

Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy
por: Doppler, Kathrin, et al.
Publicado: (2015)

Depression with Chronic Inflammatory Demyelinating Polyneuropathy
por: Marwale, Arun, et al.
Publicado: (2018)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

MOG-induced experimental autoimmune encephalomyelitis in the rat species triggers anti-neurofascin antibody response that is genetically regulated
por: Flytzani, Sevasti, et al.
Publicado: (2015)

Correction: Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy
por: Doppler, Kathrin, et al.
Publicado: (2015)

Postnatal Loss of Neuronal and Glial Neurofascins Differentially Affects Node of Ranvier Maintenance and Myelinated Axon Function
por: Taylor, Anna M., et al.
Publicado: (2017)

A Case of Paraneoplastic Demyelinating Motor Polyneuropathy
por: Mostoufizadeh, Sohrab, et al.
Publicado: (2012)

Tailoring of therapy for chronic inflammatory demyelinating polyneuropathy
por: Rajabally, Yusuf A.
Publicado: (2015)

Challenges in the diagnosis of chronic inflammatory demyelinating polyneuropathy
por: Allen, Jeffrey A., et al.
Publicado: (2018)

The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy
por: Bril, Vera, et al.
Publicado: (2016)

Anti–pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy
por: Stengel, Helena, et al.
Publicado: (2019)

Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19
por: Abu-Rumeileh, Samir, et al.
Publicado: (2020)

Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage
por: Appeltshauser, Luise, et al.
Publicado: (2022)

AIS neurofascin'd to matrix
por: Leslie, Mitch
Publicado: (2007)

Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up
por: Parisi, Mattia, et al.
Publicado: (2022)

IRIS manifesting as chronic inflammatory demyelinating polyneuropathy in HIV
por: Reghukumar, Aravind, et al.
Publicado: (2014)

Chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus
por: Fatehi, Farzad, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bkajplghektrad60se65uu5jif